The CATSPER2 gene plays a critical role in human physiology, particularly affecting male fertility and hearing capabilities. Mutations in the CATSPER2 gene can lead to a rare but significant condition characterized by deafness and male infertility. This genetic anomaly disrupts the normal functioning of sperm cells and the development of the inner ear, leading to these specific health issues.
To identify the presence of mutations in the CATSPER2 gene, a specialized genetic test is available at DNA Labs UAE. This test is designed to provide a definitive diagnosis for individuals suspected of having CATSPER2-related conditions, enabling targeted interventions and informed family planning decisions. The test involves collecting a DNA sample from the individual, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for any genetic abnormalities associated with the CATSPER2 gene.
The cost of the CATSPER2 genetic test at DNA Labs UAE is 4400 AED. This investment covers the full process of sample collection, genetic analysis, and the provision of a comprehensive report detailing the test results. Individuals considering this test are often advised to consult with a genetic counselor both before and after testing to understand the implications of the results for themselves and their families.
The "FOXF2 Gene Disorders of Sex Development with Cleft Palate Genetic Test" is a specialized diagnostic evaluation available at DNA Labs UAE, designed to identify genetic abnormalities associated with disorders of sex development (DSD) and cleft palate that are linked to mutations in the FOXF2 gene. This gene plays a crucial role in embryonic development, including the development of the reproductive system and facial structures. Mutations in the FOXF2 gene can lead to a spectrum of developmental issues, notably affecting sex differentiation and causing cleft palate, a condition characterized by a split in the roof of the mouth.
This test is particularly valuable for individuals presenting with symptoms of DSD and cleft palate, families with a history of these conditions, or healthcare providers seeking a genetic explanation for these developmental anomalies in their patients. By analyzing the DNA for specific mutations in the FOXF2 gene, this test can provide definitive diagnostic information, guide treatment decisions, and offer insight into the risk of recurrence in future pregnancies.
The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost includes the collection of a DNA sample, usually through a blood draw or cheek swab, the genetic analysis, and a comprehensive report detailing the findings. Patients and healthcare providers can use this information to better understand the condition, explore treatment options, and make informed decisions about care and management.
The FSHB gene plays a critical role in human reproductive processes. It encodes the beta subunit of the follicle-stimulating hormone (FSH), which is essential for the growth and maturation of ovarian follicles in females and the production of sperm in males. An isolated deficiency in FSH due to mutations in the FSHB gene can lead to reproductive difficulties, including delayed puberty, infertility, or reduced fertility.
DNA Labs UAE offers a genetic test specifically designed to identify mutations in the FSHB gene, which can confirm a diagnosis of isolated follicle-stimulating hormone deficiency. This test is crucial for individuals experiencing symptoms related to reproductive health who are seeking a definitive diagnosis. The test cost is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately.
Undergoing this genetic test involves providing a DNA sample, typically through a blood draw or a saliva sample, which is then analyzed in the laboratory for any genetic variations in the FSHB gene that are known to cause the condition. The results can provide valuable information for affected individuals and their healthcare providers to make informed decisions regarding treatment and management options, potentially including hormone replacement therapy or other interventions to address infertility and support reproductive health.
The HOXA13 gene plays a crucial role in the development of limbs and the gastrointestinal tract during embryonic stages. Mutations in this gene are associated with Guttmacher syndrome, a rare genetic disorder characterized by limb malformations, gastrointestinal abnormalities, and genitourinary defects. To diagnose this condition, a genetic test targeting the HOXA13 gene can be conducted, providing crucial information for affected families regarding treatment and management options.
DNA Labs UAE offers a comprehensive genetic test for Guttmacher syndrome, focusing on the HOXA13 gene. This test is essential for families with a history of the syndrome or presenting symptoms in a newborn. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed to detect any mutations in the HOXA13 gene that are indicative of Guttmacher syndrome.
The cost of the HOXA13 gene Guttmacher syndrome genetic test at DNA Labs UAE is 4400 AED. This price includes the full analysis and a detailed report that can be used by healthcare professionals to guide further treatment and management strategies. Given the complexity and rarity of Guttmacher syndrome, this test represents a valuable tool for affected individuals and their families, offering insights that can significantly impact their healthcare journey.
The HOXA13 gene plays a crucial role in the development of limbs and the urogenital tract in humans. Mutations in the HOXA13 gene can lead to Hand-foot-uterus syndrome, a rare genetic disorder characterized by malformations of the hands, feet, and uterus. Individuals with this condition may experience a range of symptoms, including limb abnormalities, such as short fingers and toes, and, in females, uterine malformations that can lead to reproductive challenges.
To diagnose this condition, a genetic test targeting the HOXA13 gene can be conducted. This test involves analyzing the DNA to identify mutations in the HOXA13 gene that are indicative of Hand-foot-uterus syndrome. It is a crucial step for affected families in understanding the condition, its implications, and potential management strategies.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with advanced genetic testing technologies to provide accurate and reliable results for individuals undergoing this test. Opting for this test at DNA Labs UAE ensures a professional and comprehensive approach to diagnosing and understanding Hand-foot-uterus syndrome, supported by the expertise of leading genetic specialists in the region.
The NLRP7 Gene Hydatidiform Mole Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the NLRP7 gene, which are closely associated with the development of hydatidiform mole, a rare pregnancy complication characterized by abnormal growth of trophoblasts, the cells that normally develop into the placenta. This condition can manifest as a complete or partial mole, leading to varying degrees of pregnancy loss and, in some cases, increasing the risk of gestational trophoblastic disease, including choriocarcinoma.
By analyzing the genetic makeup of individuals, particularly those with a history of recurrent molar pregnancies or families with a history of this condition, the test aims to provide valuable insights into the risk factors and potential for recurrence in future pregnancies. The knowledge gained from this test can guide healthcare professionals in managing and counseling affected individuals or couples regarding their reproductive health and choices.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the NLRP7 Gene Hydatidiform Mole Genetic Test is set at 4400 AED, reflecting the sophisticated nature of the analysis and the specialized expertise required to interpret the results. This investment in genetic testing can be a crucial step for those affected by hydatidiform mole, offering them a clearer understanding of their condition and informing their future pregnancy planning and management strategies.
The KHDC3L gene hydatidiform mole recurrent type 2 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the KHDC3L gene, which are associated with the development of recurrent hydatidiform mole (RHM), a rare type of gestational trophoblastic disease. This condition is characterized by the abnormal growth of trophoblasts, the cells that normally develop into the placenta during pregnancy. Women with mutations in the KHDC3L gene are at a higher risk of experiencing recurrent molar pregnancies, which can have significant implications for fertility and overall health.
This genetic test is conducted to help understand the genetic basis of recurrent hydatidiform moles in affected individuals, providing crucial information for family planning and management of future pregnancies. It involves collecting a DNA sample, usually through a blood draw, and analyzing it for specific mutations in the KHDC3L gene.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the KHDC3L gene hydatidiform mole recurrent type 2 genetic test is set at 4400 AED. This price may cover the genetic analysis, the expertise of the genetic counselors, and the comprehensive report provided after the test, which offers insight into the patient's genetic predisposition to RHM and guidance on potential next steps for managing the condition.
The KISS1 Gene Hypogonadotropic Hypogonadism Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify mutations in the KISS1 gene that are associated with hypogonadotropic hypogonadism (HH). This condition is characterized by a lack of sexual development and infertility due to insufficient production of gonadotropin-releasing hormone (GnRH), which is essential for the stimulation of the reproductive hormone system. The KISS1 gene plays a crucial role in the regulation of GnRH secretion, and mutations can lead to disrupted signaling pathways, resulting in HH.
Priced at 4400 AED, this genetic test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the state-of-the-art facilities at DNA Labs UAE. The test aims to provide a definitive diagnosis for individuals exhibiting symptoms of HH, or for those with a family history of the condition, aiding in the management and treatment planning. It offers valuable insights into the genetic underpinnings of the patient's condition, enabling personalized therapeutic strategies and informing family planning decisions.
The NSMF Gene Hypogonadotropic Hypogonadism Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the NSMF gene that are associated with hypogonadotropic hypogonadism. This condition is characterized by a failure of the gonads to produce sex hormones due to a deficiency in the gonadotropin-releasing hormone (GnRH). The test plays a crucial role in diagnosing the genetic underpinnings of this condition, which can significantly impact an individual's reproductive health and overall development.
Conducted at the state-of-the-art facilities of DNA Labs UAE, this test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed for specific mutations in the NSMF gene, which have been linked to the development of hypogonadotropic hypogonadism. Identifying these mutations can aid in confirming a diagnosis, understanding the severity of the condition, and guiding treatment decisions.
The cost of the NSMF Gene Hypogonadotropic Hypogonadism Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the advanced genetic sequencing technologies used and the expertise required to interpret the results accurately. For patients and families affected by hypogonadotropic hypogonadism, this test offers valuable insights into the genetic factors contributing to the condition, enabling a more targeted approach to treatment and management.
The FGF8 Gene Hypogonadotropic Hypogonadism Type 6 with or Without Anosmia Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE. This test is specifically designed to identify mutations in the FGF8 gene, which are known to cause Hypogonadotropic Hypogonadism Type 6, a condition characterized by delayed or absent puberty and an impaired sense of smell (anosmia) in some cases. The FGF8 gene plays a critical role in the development of the reproductive system and the olfactory system, making its mutations a key factor in the diagnosis of this condition.
The test involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of genetic abnormalities in the FGF8 gene. The results from this test can provide valuable information for the diagnosis and management of individuals with suspected Hypogonadotropic Hypogonadism Type 6, allowing for appropriate treatment and counseling.
The cost of the FGF8 Gene Hypogonadotropic Hypogonadism Type 6 with or Without Anosmia Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, including the collection of the sample, the genetic analysis, and the provision of a detailed report on the findings. Patients seeking this test at DNA Labs UAE can expect high-quality service and accurate results, backed by the expertise of the laboratory's genetic specialists.
